SCHEMBL343269

SCHEMBL343269

CC(C)Sc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45
MGLL Q99685 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
LMNA P02545 3/20 0.41
L3MBTL1 Q9Y468 4/20 0.40
MAP2K7 O14733 1/20 0.40
CDC25A P30304 1/20 0.40
CDC25B P30305 1/20 0.40
VCP P55072 1/20 0.40
ALDH1A1 P00352 2/20 0.39
MAPK1 P28482 1/20 0.39
SLC6A4 P31645 1/20 0.39
GAA P10253 2/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL1336886 0.97 MAOA (0.48) SMN1; SMN2MAPTHPGDMGLLHSD17B10
SCHEMBL21382360 0.90 LMNA (0.40) SMN1; SMN2MAPTHPGDMGLLHSD17B10
SCHEMBL19391185 0.90 SLC6A4 (0.52) SMN1; SMN2MAPTHPGDMGLLHSD17B10
Acetic Acid SCHEMBL22497414 0.88 LMNA (0.47) SMN1; SMN2MAPTHPGDHSD17B10LMNA
SCHEMBL12510868 0.85 ALDH1A1 (0.43) SMN1; SMN2HSD17B10LMNAL3MBTL1ALDH1A1
SCHEMBL1453001 0.82 SMN1; SMN2 (0.45) SMN1; SMN2MAPTHPGDMGLLHSD17B10
SCHEMBL5173197 0.82 SMN1; SMN2 (0.45) SMN1; SMN2MAPTHPGDMGLLHSD17B10
SCHEMBL1713865 0.81 SMN1; SMN2 (0.50) SMN1; SMN2MAPTHPGDMGLLHSD17B10
SCHEMBL13339048 0.79 ALDH1A1 (0.45) SMN1; SMN2MAPTMGLLLMNAL3MBTL1
SCHEMBL15209027 0.79 ALDH1A1 (0.50) SMN1; SMN2MAPTHPGDHSD17B10MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 382 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565378-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA Sicpa Holding SA (CH) 2025-06-11 EP claimed
US-20250075147-A1 FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS OSMO LABS, PBC 2025-03-06 US claimed
WO-2024028408-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2024-02-08 WO claimed
US-20240010996-A1 Bacterial unspecific peroxygenases (BUPO's) and methods and uses thereof GECCO BIOTECH B.V. (NL) 2024-01-11 US claimed
CN-116568818-A Bacterial non-specific peroxygenase (BUPO) and method and use thereof 吉柯生物科技有限公司 2023-08-08 CN claimed
EP-4217474-A1 BACTERIAL UNSPECIFIC PEROXYGENASES (BUPO'S) AND METHODS AND USES THEREOF Gecco Biotech B.V. (NL) 2023-08-02 EP claimed
WO-2022066007-A1 BACTERIAL UNSPECIFIC PEROXYGENASES (BUPO'S) AND METHODS AND USES THEREOF GECCO BIOTECH B.V. (NL) 2022-03-31 WO claimed
EP-0365328-B1 Pyridine derivatives ZENECA LTD (GB) 1996-04-03 EP claimed
US-5053415-A Antiischemic, antiinflammatory, antiarthritic agents, cardiovascular disorders IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-10-01 US claimed
EP-0365328-A2 Pyridine derivatives ZENECA LIMITED (GB) 1990-04-25 EP claimed
US-4059699-A O,O-diethyl-O-carboxamidophosphate esters and use to combat insects and mites GULF OIL CORPORATION (US) 1977-11-22 US claimed
US-3994997-A MITICIDES, INSECTICIDES GULF OIL CORPORATION (US) 1976-11-30 US claimed
US-12540073-B2 Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor BRILLIANT LIGHT POWER, INC. (US) 2026-02-03 US disclosed
US-20250075147-A1 FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS OSMO LABS, PBC 2025-03-06 US disclosed
US-12100809-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
US-20240297344-A1 NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-05 US disclosed
US-4035375-A N-Substituted amino pyridines and derivatives thereof THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 1977-07-12 US disclosed
US-3994997-A MITICIDES, INSECTICIDES GULF OIL CORPORATION (US) 1976-11-30 US disclosed
US-3994997-A MITICIDES, INSECTICIDES GULF OIL CORPORATION (US) 1976-11-30 US disclosed
US-3985756-A Process for producing azasulfonium salts and rearrangement thereof to thio-ethers THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 1976-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12540073-B2 Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor SCO2, SOD1, HAO2 SMN1; SMN2 897/4885MAPT 3595/4885HPGD 2113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.